A phase 3 trial of IV immunoglobulin for Alzheimer disease. uri icon

authors

  • Relkin, Norman R
  • Raman, Rema
  • Szabo, Paul
  • Gelmont, David M
  • Fritsch, Sandor
  • Aisen, Paul S
  • Thomas, Ronald G
  • Rissman, Robert A
  • Brewer, James B
  • Rafii, Michael S
  • van Dyck, Christopher H
  • Jack, Clifford R
  • Sano, Mary
  • Knopman, David S

publication date

  • January 1, 2017